Last updated on February 2019

Phase II Study Evaluating the Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenocarcinoma .


Brief description of study

Multicenter prospective phase II study evaluating regorafenib in older patients with metastatic colorectal cancer

Clinical Study Identifier: NCT02788006

Contact Investigators or Research Sites near you

Start Over

CH

Perpignan, France

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.